williams creek gold ltd (WCX:Venture)
Michael R. Sonnenreich J.D.
Former Director, Chairman of Corporate Governance Committee, Member of Human Resources & Compensation Committee and Member of Audit Committee, Nymox Pharmaceutical Corporation
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 6 different industries.|
Mr. Michael R. Sonnenreich, JD serves as the Chairman and Chief Executive Officer of Kikaku America International. Mr. Sonnenreich serves as the President and Chief Executive Officer of Glocal Communications Corp. Ltd. He has been a Senior Partner of Michael Sonenreich since 1973. Mr. Sonnenreich served as the Chairman, Chief Executive Officer and President of Williams Creek Gold Limited until May 24, 2013. He has vast experience in the global pharmaceutical industry. ...
666 Burrard StreetPhone: 778-370-1393
Vancouver, British Columbia V6C 2X8
Board Members Memberships*
Former Director, Chairman of Corporate Governance Committee, Member of Human Resources & Compensation Committee and Member of Audit Committee
Former Director, Chairman of Compensation Committee, Member of Corporate Governance & Nominating Committee, Member of Audit Committee and Member of Financing Committee
Former Director and Chairman of Governance & Nominating Committee
Former Chairman, Chief Executive Officer, President and Member of Audit Committee
Former Chairman, Member of Audit Committee and Member of Investment Committee
University of Wisconsin - Madison
Universidad Complutense de Madrid
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Miles D. White||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|Stephen H. Rusckowski||Chief Executive Officer, President, Director and Member of Executive Committee|
Quest Diagnostics Inc.
|Douglas A. Michels||Chief Executive Officer, President and Director|
OraSure Technologies, Inc.
|Robert H. Gundel Ph.D., M.B.A.||Chief Executive Officer, President, Director and Member of Financing Committee|
Amorfix Life Sciences Ltd.
|C$266.4K||Compensation as of Fiscal Year 2013.|